The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution.

Background: Pulmonary arterial hypertension (PAH) in the setting of end-stage renal disease (ESRD) has important prognostic and therapeutic consequences. We estimated the prevalence of PAH among patients with ESRD treated with automated peritoneal dialysis (APD), investigated the effect of different variables and compared pulmonary artery pressure and cardiac function at the beginning and end of the study.

Methods: This is a 5-year study in which 31 ESRD patients on APD were recruited after fulfilling inclusion criteria.

Neuropsychiatric manifestations in a patient undergoing hemodialysis caused by treatment with oral acyclovir.

A 50-year-old woman who was being treated with hemodialysis was admitted for severe neuropsychiatric symptoms. She tested positive for antibody to hepatitis C virus. Her medical history revealed ophthalmic herpes zoster four days before her admission for which she was started on oral acyclovir (800 mg three times daily).